Not medical advice. This website is not medical advice, a diagnosis, a match to a trial, or a recommendation to join a study. Listings are plain-English rewrites of public ClinicalTrials.gov records. Whether a site is still enrolling, and whether you qualify, can only be confirmed by the study team and your clinician. Source registry: ClinicalTrials.gov. Editorial rules: methodology.
PlainTrials
RecruitingNot a traditional drug phaseinterventionalRules rewrite

Not a traditional drug phase: walking exercise for Celiac Disease

Metabolic syndrome and fatty liver is common in adolescents with celiac diseases. exercise may control these cardiovascular risk factors

Official registry: https://clinicaltrials.gov/study/NCT07832994 · Cairo University · enrollment listed as 40

What this phase means

This study does not use the classic phase 1–4 drug ladder. It may be a device, a behavior program, a surgery timing study, or an early feasibility test.

Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.

What the registry says happens

If you join, the listed intervention(s) are walking exercise. The registry lists allocation as randomized. Metabolic syndrome and fatty liver is common in adolescents with celiac diseases.

They plan to enroll about 40 people at Giza. Taking part typically means following a program (exercise, therapy, diet, or an app) plus check-ins.

Official title (unrewritten)

Metaboic Syndrome and Fatty Liver in Celiac Disease Females: Reponse to Exercise in Adolescents

Interventions: walking exercise

Primary outcome (registry wording): alanine transamianse

Who it is for (from inclusion criteria)

  • Ages 13 Years to 17 Years
  • Women only
  • nonalcholic fatty liver

Public study contact (from the registry)

Ali MA Ismail, PhD

+201005154209

ali.mohamed@pt.cu.edu.eg

Published on ClinicalTrials.gov. Contact them as a possible participant. They decide eligibility.

Sites listed on ClinicalTrials.gov

1 listed

FAQ about this NCT record

Is NCT07832994 still recruiting?

The sponsor posted status “Recruiting” on ClinicalTrials.gov at last ingest. Sites can pause independently. Confirm with the official record and the listed contact.

What phase is NCT07832994?

Not a traditional drug phase. Phase labels are FDA/ICH categories applied to the registry Phase field. They are not a finding that this study succeeded.

Can PlainTrials tell me if I qualify for NCT07832994?

No. The inclusion and exclusion lists on this page are readable extracts of the public eligibility block. Only the study team can screen you.

How to read a ClinicalTrials.gov record · Questions to ask the coordinator · Glossary